Positron Imaging Tomography for Novel Applications

Publication ID: 24-11857352_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Positron Imaging Tomography for Novel Applications,” Published Technical Disclosure No. 24-11857352_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857352_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,352.

Summary of the Inventive Concept

Expanding the core technology of positron imaging tomography imaging agent composition to detect bacterial contamination in various industries, including food, agriculture, water treatment, medical devices, and pharmaceutical manufacturing.

Background and Problem Solved

The original patent focused on treating bacterial infections in humans, but the diagnostic capabilities of positron imaging tomography can be applied to other industries where bacterial contamination is a significant concern. The new inventive concept addresses the limitations of current detection methods in these industries, providing a more accurate and efficient way to identify bacterial contamination.

Detailed Description of the Inventive Concept

The new inventive concept involves applying the positron imaging tomography imaging agent composition to various industries, including food, agriculture, water treatment, medical devices, and pharmaceutical manufacturing. The composition is used to detect bacterial contamination in these industries, enabling more accurate and efficient identification of contaminated products or systems. The new claims describe specific applications, such as monitoring food spoilage, detecting bacterial contamination in agricultural products, and identifying contamination in water treatment systems, medical devices, and pharmaceutical manufacturing processes.

Novelty and Inventive Step

The new claims introduce novel applications of the positron imaging tomography imaging agent composition, expanding its use beyond human bacterial infections to other industries. The inventive step lies in recognizing the potential of this technology to address bacterial contamination in various fields, and adapting the composition and detection methods to suit these new applications.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include modifying the composition or detection methods to accommodate specific industry requirements, such as adjusting the ratio of 4-amino-2-[18F]-fluorobenzoic acid to 4-amino-2-[19F]-fluorobenzoic acid or using different positron imaging tomography scanning protocols. Variations could also involve integrating the positron imaging tomography technology with existing detection methods or systems to enhance their accuracy and efficiency.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in various industries, including food safety, agriculture, water treatment, medical devices, and pharmaceutical manufacturing. The market demand for more accurate and efficient bacterial contamination detection methods is high, and the positron imaging tomography technology could provide a competitive advantage in these industries.

CPC Classifications

SectionClassGroup
A A61 A61B6/037
A A61 A61K51/0402
A A61 A61P31/04
C C07 C07B59/001
C C07 C07C227/12
C C07 C07C229/60

Original Patent Information

Patent NumberUS 11,857,352
TitlePositron imaging tomography imaging agent composition and method for bacterial infection
Assignee(s)The Research Foundation for The State of University New York